Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor
Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor
复制标题
熊果酸通过释放凋亡诱导因子诱导多柔比星耐药的 HepG2 细胞死亡
DOI:
10.1016/j.canlet.2010.06.010
复制
发表时间:
2010-12-01
期刊:
影响因子:
9.7
通讯作者:
Wu, Shihua
中科院分区:
文献类型:
--
作者:
Yang, Lu;Liu, Xiaozhuo;Wu, Shihua
Ursolic acid (UA), a triterpenoid compound isolated previously from Oldenlondia diffusa, which is a Traditional Chinese Medicine used to treat cancer, was found to inhibit the proliferation of doxorubicin-resistant human hepatoma cell line (R-HepG2) through apoptosis as shown by externalization of phosphatidyl serine, morphological changes and loss of mitochondria) membrane potential. UA could activate Bak but not Bax, which implied that Bak may play an important role in UA-induced apoptosis. Furthermore, the death of R-HepG2 cells induced by UA was found to be mainly through the caspase-independent apoptosis-inducing factor (AIF) signaling pathway which was evidenced by: (a) the pan-caspase inhibitor and the specific caspase inhibitor had only modest protective effect against UA; (b) UA treatment caused the nuclear translocation of AIF, which is retained in the mitochondria in untreated R-HepG2 cells; (c) cells that had been treated with human AIE-specific siRNA could resist cell death induced by UA. In addition, a further animal study showed that UA was effective against R-HepG2 cells in vivo with negligible body weight loss and damage towards the liver, heart and spleen. Most importantly, immunohistochemical staining in animal tissues also suggested that UA also significantly inhibited the growth of R-HepG2 cells in nude mice through the AIF signaling pathway. (C) 2010 Elsevier Ireland Ltd. All rights reserved.